site stats

Curr hematol malig rep影响因子

WebMay 19, 2024 · Curr Hematol Malig Rep. 2024;13:308–17. Article PubMed Google Scholar Cheminant M, Bruneau J, Malamut G, Sibon D, Guegan N, van Gils T, et al. NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study. Gut. 2024;68:1396–405. ...

SEMINARS IN HEMATOLOGY_影响因子(IF)_中科院分区_SCI期刊投 …

WebCURR HEMATOL MALIG R 润色咨询. Current Hematologic Malignancy Reports. 出版年份：暂无数据 年文章数：0 投稿命中率：暂无数据. 出版周期：Quarterly 自引率：8.0% 审稿周期：暂无数据. 前往期刊查询. 期刊讨论 中国SCI论文 期刊主页 投稿经验 杂志官网 投稿链接 作者需 ... WebCurr Hematol Malig Rep. 2024 08; 17(4):94-104. View in: PubMed. Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations. Blood Adv. 2024 08 09; 6(15):4357-4359. View in: PubMed. Feasibility and limitations of cultured skin fibroblasts for germline genetic testing in hematologic disorders. Hum Mutat. 2024 07; 43(7):950-962. ted para itau https://catesconsulting.net

Genetic features and clinical outcomes of patients with isolated …

WebMechanisms of resistance have been identified that target all described mechanisms of mAb activity including altered antigen expression or binding, impaired complement-mediated … WebJan 19, 2024 · This is a single-institution study encompassing the Mayo Clinic Cancer Center sites (Rochester, Florida, and Arizona). After institutional review board approval, we retrospectively screened for mDDX41 cases from 4524 consecutive Mayo Clinic patient samples submitted for a 42-gene MN panel next-generation sequencing clinical assay in … WebCurr Hematol Malig Rep · Dec 2024. Review. Tweeting from the Bench: Twitter and the Physician-Scientist Benefits and Challenges. Social media platforms such as Twitter are … ted portal ankara

Stammzell-Transplantation Periphere T‑Zell-Lymphome

Category:Current Hematologic Malignancy Reports-期刊论坛，投稿经验 …

Tags:Curr hematol malig rep影响因子

Curr hematol malig rep影响因子

Current Hematologic Malignancy Reports-期刊论坛，投稿经验 …

WebCurr Hematol Malig Rep 13:13–24 CrossRefPubMed Ma H, Davarifar A, Amengual JE (2024) The future of combination therapies for Peripheral T Cell Lymphoma (PTCL). Curr Hematol Malig Rep 13:13–24 CrossRef PubMed. 18. Zurück zum Zitat Mak V, Hamm J, Chhanabhai M et al (2013) Survival of patients with peripheral T‑cell lymphoma after first ... WebMay 27, 2024 · Curr. Hematol. Malig. Rep. Publication Type: Journal: Subject Area, Categories, Scope : Hematology (Q1); Cancer Research (Q2); Oncology (Q2) h-index: …

Curr hematol malig rep影响因子

Did you know?

WebCurr Hematol Malig Rep. ISSN. 1558-8211. Electronic ISSN. 1558-822X. Therapeutic Area. Hematology, Oncology. Readership. Hematologists, Oncologists. Scope. Current Hematologic Malignancy Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. WebCurr Hematol Malig Rep. 2012 Sep;7(3):208-15. doi: 10.1007/s11899-012-0132-3. Authors Kieron Dunleavy 1 , Mark Roschewski, Wyndham H Wilson. Affiliation 1 Metabolism Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA. [email protected]; PMID: 22814713 PMCID ...

WebCurr Hematol Malig Rep (2012) 7:116–124 DOI 10.1007/s11899-012-0113-6. this review attempts to clarify the current role of TK inhi-bition in pediatric patients with CML. Web慢性淋巴细胞白血病（cll）是一种共表达cd5和cd23的成熟小b淋巴细胞惰性肿瘤，患者中位发病年龄72岁，发病风险随年龄的增长而增加 [] 。 cll的治疗历经了细胞毒化疗（包含苯丁酸氮芥、氟达拉滨、环磷酰胺）、fcr（氟达拉滨+环磷酰胺+利妥昔单抗）和br（苯达莫司汀+利妥昔单抗）方案的免疫化疗 ...

WebCurr Hematol Malig Rep. 2016 Dec;11(6):514-527. PubMed PMID: 27778143 Haverkos BM, Pan Z, Gru AA, Freud AG, Rabinovitch R, Xu-Welliver M, Otto B, Barrionuevo C, Baiocchi RA, Rochford R, Porcu P. Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North … WebCurr Hematol Malig Rep. 2024 Apr;16(2):117-125. doi: 10.1007/s11899-021-00629-1. Epub 2024 Apr 16. Authors Thomas M Kuczmarski 1 , Oreofe O Odejide 2 Affiliations 1 Department of Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA. 2 Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, …

WebApr 10, 2024 · Hematopoietic autologous stem cell transplantation (ASCT) is a validated therapeutic strategy for lymphoma treatment and precise well-tolerated conditioning. Several conditioning methods are available, but the most commonly used are CVB, BEAM, and ICE, which are conventionally administered in 6-7 days. Since 2015, our program has moved …

WebCurr Hematol Malig Rep. 2024 Aug;15(4):360-371. doi: 10.1007/s11899-020-00594-1. Authors Tapan Bhavsar 1 , Genevieve M Crane 2 Affiliations 1 Department of Pathology … ted prengamanWeb期刊名称. CURR HEMATOL MALIG R/Current Hematologic Malignancy Reports. ISSN. 1558-8211. 影响指数话题. 影响指数话题. 预警等级. MedSci期刊指数. 1.351 （MedSci实 … ted penang roadhttp://jms.fudan.edu.cn/CN/abstract/abstract2305.shtml ted poley danger dangerWebCURR HEMATOL MALIG R 润色咨询. Current Hematologic Malignancy Reports. 出版年份：暂无数据 年文章数：0 投稿命中率：暂无数据. 出版周期：Quarterly 自引率：8.0% 审 … ted pendantWeb所属分类： 首页 > SCI期刊 > 医学. 期刊名： SEMINARS IN HEMATOLOGY. 期刊名缩写： SEMIN HEMATOL. 期刊ISSN： 0037-1963. E-ISSN： 1532-8686. 2024年影响因子/JCR … tedra begayWebApr 1, 2024 · SUMMARY: Lymphomas of the CNS are the second most frequent primary brain malignancy in adults after gliomas. Presurgical suspicion of lymphoma greatly impacts patient management. The radiologic features of this tumor have been widely covered in the literature for decades, but under current classifications, mainly corresponding to the most … ted pulling kora managementWebCurr Hematol Malig Rep. 2015;10:86–95. [ PubMed : 25929769 ] [ CrossRef ] Buckley SA, Wood BL, Othus M, et al. Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid … tedradail